Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)

SHE:300026 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,187	1,306	1,574	1,206	1,316	1,126
Cash & Short-Term Investments	1,187	1,306	1,574	1,206	1,316	1,126
Cash Growth	-26.62%	-17.00%	30.46%	-8.34%	16.89%	13.95%
Accounts Receivable	2,871	2,825	2,892	3,546	3,694	2,852
Other Receivables	35.59	38.34	50.09	49.94	59.23	44.68
Receivables	2,907	2,864	2,942	3,596	3,753	2,897
Inventory	1,730	1,749	1,961	2,214	1,305	1,417
Prepaid Expenses	-	12.5	13.25	32.11	16.77	-
Other Current Assets	260.51	217.18	230.06	336.93	416.22	274.33
Total Current Assets	6,084	6,149	6,720	7,385	6,806	5,714
Property, Plant & Equipment	3,090	3,149	3,242	3,322	2,901	2,556
Long-Term Investments	235.42	235.58	247.62	244.03	272.82	274
Goodwill	675.2	675.2	692.54	716.05	716.05	799.18
Other Intangible Assets	289.3	298.45	331.11	352.73	313.68	232.4
Long-Term Accounts Receivable	26.39	26.39	46.37	94.1	115.01	101.49
Long-Term Deferred Tax Assets	222.35	222.17	129.29	140.56	108.16	114.48
Long-Term Deferred Charges	383.14	386.75	402.6	327.29	311.53	343.42
Other Long-Term Assets	20.64	22.77	23.14	77.68	62.51	44.47
Total Assets	11,027	11,165	11,835	12,660	11,607	10,180
Accounts Payable	620.99	678.15	713.45	884.77	605	535.7
Accrued Expenses	13.53	299.23	184.08	444.37	519.36	321.06
Short-Term Debt	11.45	16.24	23.18	231.47	293.79	792.84
Current Portion of Long-Term Debt	121.15	150.25	167.67	380.77	100.02	4.55
Current Portion of Leases	-	45.25	25.88	55.07	45.86	-
Current Income Taxes Payable	46.61	19.4	20.61	9.82	15.12	33.04
Current Unearned Revenue	52.79	63.97	76.27	208.03	137.56	132.08
Other Current Liabilities	643.06	348.67	353.7	463.6	341.56	520.74
Total Current Liabilities	1,510	1,621	1,565	2,678	2,058	2,340
Long-Term Debt	450.6	529.17	1,257	1,345	1,458	362.03
Long-Term Leases	105.34	111.16	59.42	78.12	67.07	-
Long-Term Unearned Revenue	64.05	65.56	62.56	62.04	67.55	74.06
Long-Term Deferred Tax Liabilities	37.02	39.52	23.2	33.81	3.95	4.22
Other Long-Term Liabilities	-	-	-	-	-	7.44
Total Liabilities	2,167	2,367	2,967	4,197	3,655	2,788
Common Stock	3,004	3,004	3,004	3,004	3,004	3,004
Additional Paid-In Capital	589.89	589.89	589.49	589.49	589.49	584.28
Retained Earnings	5,103	5,043	5,112	4,695	4,199	3,642
Comprehensive Income & Other	6.96	6.83	4.75	0.86	-19.98	-36.43
Total Common Equity	8,704	8,644	8,710	8,290	7,773	7,194
Minority Interest	156.22	154.66	157.7	172.87	179.49	197.75
Shareholders' Equity	8,861	8,799	8,868	8,463	7,952	7,392
Total Liabilities & Equity	11,027	11,165	11,835	12,660	11,607	10,180
Total Debt	688.55	852.07	1,533	2,091	1,965	1,159
Net Cash (Debt)	498.38	454.12	40.24	-884.45	-648.87	-33.64
Net Cash Growth	1642.48%	1028.45%	-	-	-	-
Net Cash Per Share	0.23	0.21	0.01	-0.30	-0.22	-0.01
Filing Date Shares Outstanding	3,004	3,004	3,004	3,004	3,004	3,004
Total Common Shares Outstanding	3,004	3,004	3,004	3,004	3,004	3,004
Working Capital	4,575	4,528	5,155	4,707	4,748	3,374
Book Value Per Share	2.90	2.88	2.90	2.76	2.59	2.39
Tangible Book Value	7,740	7,670	7,686	7,221	6,743	6,163
Tangible Book Value Per Share	2.58	2.55	2.56	2.40	2.24	2.05
Buildings	-	1,986	1,988	1,730	1,651	1,605
Machinery	-	2,544	2,514	2,155	1,852	1,665
Construction In Progress	-	104.19	54.11	461.01	232.93	64.18

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.